Toxicity manifesting as cosmetic hair alterations during erlotinib treatment

Authors

  • Kenichiro Kudo Department of Respiratory Medicine, National Hospital Organization Okayama Medical Center, 1711-1 Tamasu Kita-ku, Okayama 701-1192, Japan
  • Keiichi Fujiwara Department of Respiratory Medicine, National Hospital Organization Okayama Medical Center, 1711-1 Tamasu Kita-ku, Okayama 701-1192, Japan
  • Mizuho Tsushima Department of Respiratory Medicine, National Hospital Organization Okayama Medical Center, 1711-1 Tamasu Kita-ku, Okayama 701-1192, Japan
  • Makoto Mizuta Department of Respiratory Medicine, National Hospital Organization Okayama Medical Center, 1711-1 Tamasu Kita-ku, Okayama 701-1192, Japan
  • Kiyoshi Matsuo Department of Respiratory Medicine, National Hospital Organization Okayama Medical Center, 1711-1 Tamasu Kita-ku, Okayama 701-1192, Japan
  • Toshiro Yonei Department of Respiratory Medicine, National Hospital Organization Okayama Medical Center, 1711-1 Tamasu Kita-ku, Okayama 701-1192, Japan
  • Toshio Sato Department of Respiratory Medicine, National Hospital Organization Okayama Medical Center, 1711-1 Tamasu Kita-ku, Okayama 701-1192, Japan

DOI:

https://doi.org/10.3109/0284186X.2010.509107

Abstract

No abstract available

Downloads

Download data is not yet available.

Downloads

Published

2011-01-01

How to Cite

Kudo, K., Fujiwara, K., Tsushima, M., Mizuta, M., Matsuo, K., Yonei, T., & Sato, T. (2011). Toxicity manifesting as cosmetic hair alterations during erlotinib treatment. Acta Oncologica, 50(1), 146–148. https://doi.org/10.3109/0284186X.2010.509107

Issue

Vol. 50 No. 1 (2011): Acta Oncologica

Section

Articles